Spina bifida: Difference between revisions

Jump to navigation Jump to search
M Jahan (talk | contribs)
Mohsen Basiri (talk | contribs)
mNo edit summary
 
(11 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Spina bifida}}
{{Spina bifida}}
{{CMG}}; {{AE}}, {{MMJ}}, {{M.B}}
==[[Spina bifida overview|Overview]]==


{{CMG}}; {{AE}} {{MMJ}}
==[[Spina bifida historical perspective|Historical Perspective]]==
==Pathophysiology==
* Spina bifida is a congenital malformation in which the spinal column is split (bifid) as a result of failed closure of the embryonic neural tube, during the fourth week post-fertilization.<ref name="pmid5327787">{{cite journal |vauthors=Kenworthy ME |title=Introducing the American Orthopsychiatric Association's president for 1966-67: Norman V. Lourie |journal=Am J Orthopsychiatry |volume=36 |issue=4 |pages=587–9 |date=July 1966 |pmid=5327787 |doi= |url=}}</ref>
* [[Spina bifida occulta]]: In this type of spina bifida, the defect of [[vertebrate]] is covered by [[skin]] ("Occulta" means "hidden"). The [[spinal cord]] does not stick out through the skin, although the skin over the lower spine may have a patch of hair, a [[birthmark]], or a dimple above the groove between the [[buttocks]].<ref name="pmid5327787">{{cite journal |vauthors=Kenworthy ME |title=Introducing the American Orthopsychiatric Association's president for 1966-67: Norman V. Lourie |journal=Am J Orthopsychiatry |volume=36 |issue=4 |pages=587–9 |date=July 1966 |pmid=5327787 |doi= |url=}}</ref>
* Spina ifida aperta: In this type of spina bifida , the defect is widely open and is sub classified  into 2 types: Meningocele and Myelomeningocele.<ref name="pmid5327787">{{cite journal |vauthors=Kenworthy ME |title=Introducing the American Orthopsychiatric Association's president for 1966-67: Norman V. Lourie |journal=Am J Orthopsychiatry |volume=36 |issue=4 |pages=587–9 |date=July 1966 |pmid=5327787 |doi= |url=}}</ref>
==Risk Factors==
*Common risk factors in the development of spina bifida are disturbed [[folate]]/[[homocysteine]] metabolism<ref name="pmid21207040">{{cite journal |vauthors=De Marco P, Merello E, Calevo MG, Mascelli S, Pastorino D, Crocetti L, De Biasio P, Piatelli G, Cama A, Capra V |title=Maternal periconceptional factors affect the risk of spina bifida-affected pregnancies: an Italian case-control study |journal=Childs Nerv Syst |volume=27 |issue=7 |pages=1073–81 |date=July 2011 |pmid=21207040 |doi=10.1007/s00381-010-1372-y |url=}}</ref><ref name="pmid24078478">{{cite journal |vauthors=Kondo A, Morota N, Ihara S, Saisu T, Inoue K, Shimokawa S, Fujimaki H, Matsuo K, Shimosuka Y, Watanabe T |title=Risk factors for the occurrence of spina bifida (a case-control study) and the prevalence rate of spina bifida in Japan |journal=Birth Defects Res. Part A Clin. Mol. Teratol. |volume=97 |issue=9 |pages=610–5 |date=September 2013 |pmid=24078478 |doi=10.1002/bdra.23179 |url=}}</ref>, presence of spina bifida patients within third-degree relatives<ref name="pmid24078478">{{cite journal |vauthors=Kondo A, Morota N, Ihara S, Saisu T, Inoue K, Shimokawa S, Fujimaki H, Matsuo K, Shimosuka Y, Watanabe T |title=Risk factors for the occurrence of spina bifida (a case-control study) and the prevalence rate of spina bifida in Japan |journal=Birth Defects Res. Part A Clin. Mol. Teratol. |volume=97 |issue=9 |pages=610–5 |date=September 2013 |pmid=24078478 |doi=10.1002/bdra.23179 |url=}}</ref>, taking [[Anti-epileptic drugs|anti-epileptic]] drugs without [[Folic Acid|folic acid]]<ref name="pmid24078478">{{cite journal |vauthors=Kondo A, Morota N, Ihara S, Saisu T, Inoue K, Shimokawa S, Fujimaki H, Matsuo K, Shimosuka Y, Watanabe T |title=Risk factors for the occurrence of spina bifida (a case-control study) and the prevalence rate of spina bifida in Japan |journal=Birth Defects Res. Part A Clin. Mol. Teratol. |volume=97 |issue=9 |pages=610–5 |date=September 2013 |pmid=24078478 |doi=10.1002/bdra.23179 |url=}}</ref>[[Folic Acid|,]] and [[low birth weight]] in the [[newborns]] ≤ 2500 g.<ref name="pmid24078478">{{cite journal |vauthors=Kondo A, Morota N, Ihara S, Saisu T, Inoue K, Shimokawa S, Fujimaki H, Matsuo K, Shimosuka Y, Watanabe T |title=Risk factors for the occurrence of spina bifida (a case-control study) and the prevalence rate of spina bifida in Japan |journal=Birth Defects Res. Part A Clin. Mol. Teratol. |volume=97 |issue=9 |pages=610–5 |date=September 2013 |pmid=24078478 |doi=10.1002/bdra.23179 |url=}}</ref>


== Diagnosis ==
==[[Spina bifida classification|Classification]]==
=== Symptoms ===


=== Physical examination ===
==[[Spina bifida pathophysiology|Pathophysiology]]==
*Physical examination of patients with spina bifida may be remarkable for:<ref name="pmid4898641">{{cite journal |vauthors=Bannur BB, Purandare GM |title=Microbial production of L-lysine |journal=Hindustan Antibiot Bull |volume=11 |issue=3 |pages=191–205 |date=February 1969 |pmid=4898641 |doi= |url=}}</ref><ref name="pmid5327787">{{cite journal |vauthors=Kenworthy ME |title=Introducing the American Orthopsychiatric Association's president for 1966-67: Norman V. Lourie |journal=Am J Orthopsychiatry |volume=36 |issue=4 |pages=587–9 |date=July 1966 |pmid=5327787 |doi= |url=}}</ref>
:* Spinal area discoloration or [[birthmarks]] may be the only sign in the newborns with spina bifida occulta
:* Protrusions in the [[lumbar spine]]
:* Dimples  in the [[lumbar spine]]
:* Hair patch along the spine


:*[[Hydrocephalus]] signs may be present:
==[[Spina bifida causes|Causes]]==
:**Enlarging head
:**Bulging [[fontanelle]]
:**Enlarged [[scalp veins]]
:**[[Cranial bones]] [[suture]] [[diastasis]]
:**Positive [[Macewen's sign|Macewen sign]]
:*[[Paralysis]]
:*Sensation problems
:*[[Scoliosis]]
:*Pressure [[Ulcer|ulcers]]
:*Learning disabilities


=== Laboratory Findings ===
==[[Spina bifida differential diagnosis|Differentiating Spina bifida from other Diseases]]==
*There are no specific laboratory findings associated with spina bifida.


*An elevated concentration of Maternal Serum [[Alpha-fetoprotein|Alpha-Fetoprotein]] may be predictive for contemporary detection of spina bifida.<ref name="pmid26332586">{{cite journal |vauthors=Racusin DA, Villarreal S, Antony KM, Harris RA, Mastrobattista J, Lee W, Shamshirsaz AA, Belfort M, Aagaard KM |title=Role of Maternal Serum Alpha-Fetoprotein and Ultrasonography in Contemporary Detection of Spina Bifida |journal=Am J Perinatol |volume=32 |issue=14 |pages=1287–91 |date=December 2015 |pmid=26332586 |doi=10.1055/s-0035-1562930 |url=}}</ref>
==[[Spina bifida epidemiology and demographics|Epidemiology and Demographics]]==


===Imaging Findings===
==[[Spina bifida risk factors|Risk Factors]]==
*Three-dimensional ultrasound is the imaging modality of choice for characterisation of the open spina bifida spinal lesions.<ref name="pmid24373566">{{cite journal |vauthors=Trudell AS, Odibo AO |title=Diagnosis of spina bifida on ultrasound: always termination? |journal=Best Pract Res Clin Obstet Gynaecol |volume=28 |issue=3 |pages=367–77 |date=April 2014 |pmid=24373566 |doi=10.1016/j.bpobgyn.2013.10.006 |url=}}</ref>
*Ultrasound also is the gold standard diagnostic tool for spina bifida.<ref name="pmid24373566">{{cite journal |vauthors=Trudell AS, Odibo AO |title=Diagnosis of spina bifida on ultrasound: always termination? |journal=Best Pract Res Clin Obstet Gynaecol |volume=28 |issue=3 |pages=367–77 |date=April 2014 |pmid=24373566 |doi=10.1016/j.bpobgyn.2013.10.006 |url=}}</ref>
*On Three-dimensional ultrasound, spina bifida is characterized by:<ref name="pmid12054297">{{cite journal |vauthors=Lee W, Chaiworapongsa T, Romero R, Williams R, McNie B, Johnson A, Treadwell M, Comstock CH |title=A diagnostic approach for the evaluation of spina bifida by three-dimensional ultrasonography |journal=J Ultrasound Med |volume=21 |issue=6 |pages=619–26 |date=June 2002 |pmid=12054297 |doi= |url=}}</ref>
**[[Vertebral anomalies|Vertebral defect]]
**Splayed [[Vertebral|vertebral pedicles]]
**Disrupted [[vertebrae]]
== Treatment ==
=== Surgery ===
*Prenatal surgery is the preferred treatment for spina bifida and it usually is done before the 26th week of [[pregnancy]].<ref name="pmid2293328">{{cite journal |vauthors=Ciovîrnache M, Simionescu L, Ioaniţiu D |title=[A study of palmar flexion folds by the Perera-Kolski quantitative method in acromegaly] |language=French |journal=Endocrinologie |volume=28 |issue=2 |pages=57–62 |date=1990 |pmid=2293328 |doi= |url=}}</ref><ref name="pmid3963040">{{cite journal |vauthors=Tilles DS, Goldenheim PD, Johnson DC, Mendelson JH, Mello NK, Hales CA |title=Marijuana smoking as cause of reduction in single-breath carbon monoxide diffusing capacity |journal=Am. J. Med. |volume=80 |issue=4 |pages=601–6 |date=April 1986 |pmid=3963040 |doi= |url=}}</ref>
*Intrauterine repair of spina bifida confers multiple advantages to [[infants]], including:<ref name="pmid3963040">{{cite journal |vauthors=Tilles DS, Goldenheim PD, Johnson DC, Mendelson JH, Mello NK, Hales CA |title=Marijuana smoking as cause of reduction in single-breath carbon monoxide diffusing capacity |journal=Am. J. Med. |volume=80 |issue=4 |pages=601–6 |date=April 1986 |pmid=3963040 |doi= |url=}}</ref>
**Lower rates of [[shunt]] dependency
**Lower rates of [[hindbrain]] [[herniation]]
**Better motor and disability functional outcomes
*Surgery after birth is done in patients who did not underwent prenatal surgery but the prognosis is worse and there are more possible complications after [[surgery]] in comparison with the prenatal [[surgery]].


=== Prevention ===
==[[Spina bifida screening|Screening]]==
*A protective effect of [[folate]] against the development of [[neural tube defect]]s (NTDs), specifically, spina bifida, is now well recognized, having been established by a lot of clinical research studies over the past half-century.<ref name="pmid17209211">{{cite journal |vauthors=Pitkin RM |title=Folate and neural tube defects |journal=Am. J. Clin. Nutr. |volume=85 |issue=1 |pages=285S–288S |date=January 2007 |pmid=17209211 |doi=10.1093/ajcn/85.1.285S |url=}}</ref>
*Effective measures for the primary prevention of spina bifida include:<ref name="pmid3504607">{{cite journal |vauthors=Srb V, Kubzová E |title=[Comparison of the effects of 1st and 3d generation platinum cytostatics on the chromosomes of lymphocytes in human peripheral blood in vitro] |language=Czech |journal=Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl |volume=30 |issue=4 |pages=475–83 |date=1987 |pmid=3504607 |doi= |url=}}</ref>
**Not drinking alcohol
**Not smoking
**Not taking drugs
**Taking [[Folic Acid]]
*Taking oral daily [[folate]] is recommended for all pregnant women.<ref name="pmid17209211">{{cite journal |vauthors=Pitkin RM |title=Folate and neural tube defects |journal=Am. J. Clin. Nutr. |volume=85 |issue=1 |pages=285S–288S |date=January 2007 |pmid=17209211 |doi=10.1093/ajcn/85.1.285S |url=}}</ref>
*Neural tube closure is completed 28 days (four weeks) from conception, and the preventive effect of folic acid is not effective after that period.<ref name="pmid3279093">{{cite journal |vauthors=Alt TH |title=Aids to scalp reduction surgery |journal=J Dermatol Surg Oncol |volume=14 |issue=3 |pages=309–15 |date=March 1988 |pmid=3279093 |doi= |url=}}</ref>
*So, folate supplementation should start at least 4 weeks before conception and it should continue until at least two months after conception.<ref name="pmid3279093">{{cite journal |vauthors=Alt TH |title=Aids to scalp reduction surgery |journal=J Dermatol Surg Oncol |volume=14 |issue=3 |pages=309–15 |date=March 1988 |pmid=3279093 |doi= |url=}}</ref>
*The recommended intakes of [[folate]] are 4 mg/d for those at high-risk pregnancies(by virtue of a previous NTD pregnancy outcome) and 0.4 mg/d for all others.<ref name="pmid17209211">{{cite journal |vauthors=Pitkin RM |title=Folate and neural tube defects |journal=Am. J. Clin. Nutr. |volume=85 |issue=1 |pages=285S–288S |date=January 2007 |pmid=17209211 |doi=10.1093/ajcn/85.1.285S |url=}}</ref>


==References==
==[[Spina bifida natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
{{Reflist|2}}


{{WS}}
==Diagnosis==
{{WH}}
[[Spina bifida diagnostic study of choice|Diagnostic study of choice]] | [[Spina bifida history and symptoms|History and Symptoms]] | [[Spina bifida physical examination|Physical Examination]] | [[Spina bifida laboratory findings|Laboratory Findings]] | [[Spina bifida electroencephalogram|Electroencephalogram]] | [[Spina bifida x ray|X-Ray Findings]] | [[Spina bifida echocardiography and ultrasound|Echocardiography and Ultrasound]] | [[Spina bifida CT scan|CT-Scan Findings]] | [[Spina bifida MRI|MRI Findings]] | [[Spina bifida other imaging findings|Other Imaging Findings]] | [[Spina bifida other diagnostic studies|Other Diagnostic Studies]]
 
==Treatment==
[[Spina bifida medical therapy|Medical Therapy]] | [[Spina bifida surgery|Surgery]] | [[Spina bifida primary prevention|Primary Prevention]]
 
==Case Studies==
[[Spina bifida case study one|Case #1]]
 
[[Category: (name of the system)]]

Latest revision as of 02:29, 15 March 2021

Spina bifida Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Spina Bifida from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electroencephalogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Spina bifida On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Spina bifida

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Spina bifida

CDC on Spina bifida

Spina bifida in the news

Blogs on Spina bifida

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Spina bifida

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: , Mohamadmostafa Jahansouz M.D.[2], Mohsen Basiri M.D.

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Spina bifida from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electroencephalogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention

Case Studies

Case #1